Ali Rezaie, MD, MSc Epi, FRCPC

​

Director, GI Motility Program

Cedars-Sinai Medical Center

Los Angeles, California

​

​

Dr. Rezaie completed his residency and fellowship in internal medicine and gastroenterology at the University of Alberta and Calgary, respectively. Further he obtained a Master of Science degree in Epidemiology and administrative data analysis at the University of Calgary, Canada. He has completed one year of advanced postdoctoral training in inflammatory bowel diseases at the University of Calgary and a year of advanced gastrointestinal motility training at Cedars-Sinai Medical Center, Los Angeles.

 

He has been awarded multiple grants for his research including the Canadian Institute of Health Research.  His primary research interests involve irritable bowel syndrome, motility disorders of patients with inflammatory bowel disease and population-based data analysis. He has authored and co-authored more than 50 peer-reviewed publications and his works have been cited more 3,000 times.

 

 

Speaker Disclosure Statement:

Ali Rezaie, MD, MSc Epi, FRCPC, has disclosed that he has participated on the speaker’s bureau , and has and has served as a consultant for Salix, Bayer, and Synergy. He has received grants from Salix. Additionally, he has served as a board member for Gemelli Biotec.